TMO · 10-Q · 2026Q3 · Full report

Revenue Performance and Mix

THERMO FISHER SCIENTIFIC INC. · 2026-10-30 · Importance 36 · Surprise 14

Third-quarter 2026 revenue was $12.137 billion, up 9.1% from $11.122 billion a year earlier; revenue for the first nine months was $35.136 billion, up 8.6% from $32.341 billion. Third-quarter segment revenue was $6.863 billion in Laboratory Products and Biopharma Services, $2.719 billion in Life Sciences Solutions, $2.002 billion in Analytical Instruments, and $1.098 billion in Specialty Diagnostics. Laboratory Products and Biopharma Services led segment contributions to organic revenue in both the quarter and nine-month period; its nine-month revenue rose to $19.592 billion from $17.605 billion, while Specialty Diagnostics revenue declined to $3.445 billion from $3.456 billion. In the third quarter, reported growth in Laboratory Products and Biopharma Services included $425 million from clinical research, $306 million from pharma services, and $169 million from the research and safety market channel.

Key facts